Safety study of SSS55 in healthy volunteers
This trial is testing a new medicine called SSS55 in healthy adults to see if it is safe and how the body processes it. Participants will receive meningococcal and pneumococcal vaccines before the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 to 45 years old
- In good general health with no serious medical conditions
- BMI between 19 and 28, with a minimum weight of 50 kg (men) or 45 kg (women)
- Must be willing to receive two vaccines (meningococcal and pneumococcal) at least 14 days before the study starts
- No history of drug or food allergies, recurrent infections, or recent use of antibiotics
- No active infections like hepatitis B or C, HIV, or syphilis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety test of a new injectable drug (SSS68) in healthy volunteers with no serious medical conditions. Researchers will give one dose under the skin and monitor how your body tolerates it over time.
This study tests a new drug called SLN12140 in healthy adults to see how safe it is and how the body processes it. You will need to have had certain vaccines beforehand and be willing to follow a detailed schedule of check-ups and procedures.
This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.
This trial tests a new medicine called HS-20152 in healthy people to see if it is safe and how the body handles it. Participants will receive vaccinations before the study to protect against certain infections.
This study tests a single dose of a new medication called SYH2061 to see if it is safe and how the body processes it. It is for healthy adults aged 18 to 55 who have had certain vaccines and are willing to follow study rules.
This study tests a new drug called SSS67 given as a single injection into a vein. It aims to see how safe it is in healthy adults and how the body processes it.
Hear when a new Safety Issues trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.